Revival Point^®, a leader in natural health supplements for aging adults, today announced the launch of Muscle Genesis^®, a new product designed to enhance muscle health and improve fat utilization. The launch comes as interest in metabolic health solutions, such as GLP-1 agonists, continues to surge across the nation.

Muscle Genesis features myHMB^®, a clinically tested ingredient that has shown significant benefits in muscle preservation and fat loss, especially during calorie-restricted diets. Published studies have demonstrated that myHMB^® helps athletes and non-athletes alike maintain muscle mass and improve body composition through enhanced fat breakdown and utilization.

Groundbreaking Sports/Active Clinical Studies

Revival Point’s new supplement is backed by compelling research, as evidenced in several published studies:

Athlete Muscle Preservation: Studies have shown myHMB^® helps maintain muscle mass during significant weight loss strategies, such as those used by combat sports athletes.

Intermittent Fasting Body Composition: Research indicates myHMB^® uniquely supports fat loss while preserving muscle in those practicing intermittent fasting.

Caloric Restriction in Athletes: In controlled settings, myHMB^® has been proven to enhance fat loss and maintain muscle mass, crucial for athletic performance.

General Population Weight Management: Further studies reveal myHMB^® significantly improves body composition in non-exercising overweight women, reducing weight and body fat measurably.

“Muscle Genesis is not just another supplement; it’s a scientifically backed solution that supports the body’s ability to maintain muscle while managing weight,” said Kendal LaFleur, Head of Product Development at Revival Point^®. “For a growing number of consumers and healthcare professionals, it’s not just about shedding pounds. It’s about building a healthy, functional body to promote long-term health, functionality, and quality of life.”

References

https://pubmed.ncbi.nlm.nih.gov/38149561/.
https://pubmed.ncbi.nlm.nih.gov/31268131/.
www.sciencedirect.com/science/article/pii/S1728869X1060007X.
www.sciencedirect.com/science/article/abs/pii/S2451847619300375.
www.mdpi.com/2072-6643/14/21/4674.
www.cnbc.com/2023/10/23/wall-street-hikes-forecasts-for-anti-obesity-drug-sales-to-100-billion.html.